Oppenheimer & Co’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $232K | Buy |
|
|||||
|
2025
Q2 | $169K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $227K | Sell |
|
|||||
|
2024
Q3 | $584K | Buy |
|
|||||
|
2024
Q2 | $312K | Buy |
|
|||||
|
2024
Q1 | $191K | Buy |
|
|||||
|
2023
Q4 | $129K | Sell |
|
|||||
|
2023
Q3 | $137K | Sell |
|
|||||
|
2023
Q2 | $135K | Sell |
|
|||||
|
2023
Q1 | $558K | Sell |
|
|||||
|
2022
Q4 | $643K | Sell |
|
|||||
|
2022
Q3 | $623K | Buy |
|
|||||
|
2022
Q2 | $554K | Sell |
|
|||||
|
2022
Q1 | $861K | Buy |
|
|||||
|
2021
Q4 | $381K | Sell |
|
|||||
|
2021
Q3 | $511K | Sell |
|
|||||
|
2021
Q2 | $606K | Sell |
|
|||||
|
2021
Q1 | $814K | Sell |
|
|||||
|
2020
Q4 | $734K | Sell |
|
|||||
|
2020
Q3 | $935K | Buy |
|
|||||
|
2020
Q2 | $1.25M | Sell |
|
|||||
|
2020
Q1 | $1.43M | Buy |
|
|||||
|
2019
Q4 | $935K | Sell |
|
|||||
|
2019
Q3 | $687K | Sell |
|
|||||
|
2019
Q2 | $1.05M | Sell |
|
|||||
|
2019
Q1 | $1.85M | Sell |
|
|||||
|
2018
Q4 | $1.95M | Sell |
|
|||||
|
2018
Q3 | $2.76M | Buy |
|
|||||
|
2018
Q2 | $2.83M | Buy |
|
|||||
|
2018
Q1 | $1.79M | Sell |
|
|||||
|
2017
Q4 | $2.34M | Sell |
|
|||||
|
2017
Q3 | $2.65M | Buy |
|
|||||
|
2017
Q2 | $4.83M | Sell |
|
|||||
|
2017
Q1 | $4.83M | Sell |
|
|||||
|
2016
Q4 | $6.5M | Buy |
|
|||||
|
2016
Q3 | $2.96M | Sell |
|
|||||
|
2016
Q2 | $5.76M | Buy |
|
|||||
|
2016
Q1 | $4.65M | Sell |
|
|||||
|
2015
Q4 | $6.01M | Sell |
|
|||||
|
2015
Q3 | $6.67M | Buy |
|
|||||
|
2015
Q2 | $6.61M | Sell |
|
|||||
|
2015
Q1 | $7.25M | Buy |
|
|||||
|
2014
Q4 | $6.57M | Sell |
|
|||||
|
2014
Q3 | $7.89M | Sell |
|
|||||
|
2014
Q2 | $8.01M | Buy |
|
|||||
|
2014
Q1 | $7.96M | Buy |
|
|||||
|
2013
Q4 | $5.59M | Buy |
|
|||||
|
2013
Q3 | $4.75M | Buy |
|
|||||
|
2013
Q2 | $4.81M | Buy |
|